Copernicus Capital Management as of Sept. 30, 2021
Portfolio Holdings for Copernicus Capital Management
Copernicus Capital Management holds 13 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Pfizer (PFE) | 15.6 | $1.3M | 30k | 43.00 | |
| Thermo Fisher Scientific (TMO) | 13.8 | $1.1M | 2.0k | 571.50 | |
| Teladoc (TDOC) | 10.7 | $888k | 7.0k | 126.86 | |
| BioMarin Pharmaceutical (BMRN) | 10.3 | $850k | 11k | 77.27 | |
| Johnson & Johnson (JNJ) | 9.8 | $808k | 5.0k | 161.60 | |
| Fate Therapeutics (FATE) | 8.6 | $711k | 12k | 59.25 | |
| Horizon Therapeutics Pub L SHS | 8.0 | $657k | 6.0k | 109.50 | |
| Arcus Biosciences Incorporated (RCUS) | 7.2 | $593k | 17k | 34.88 | |
| Allogene Therapeutics (ALLO) | 4.7 | $386k | 15k | 25.73 | |
| Medtronic SHS (MDT) | 4.6 | $376k | 3.0k | 125.33 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 4.1 | $335k | 40k | 8.38 | |
| Immatics SHS (IMTX) | 1.6 | $130k | 10k | 13.00 | |
| Amicus Therapeutics (FOLD) | 1.2 | $96k | 10k | 9.60 |
